ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
131 hedge funds and large institutions have $221M invested in iTeos Therapeutics in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
16% less capital invested
Capital invested by funds: $262M → $221M (-$41.5M)
78% less call options, than puts
Call options by funds: $1.02M | Put options by funds: $4.67M
Holders
131
Holding in Top 10
1
Calls
$1.02M
Puts
$4.67M
Top Buyers
| 1 | +$14.7M | |
| 2 | +$9.29M | |
| 3 | +$4.97M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$4.48M |
| 5 |
BlackRock
New York
|
+$4.23M |
Top Sellers
| 1 | -$7.27M | |
| 2 | -$4.98M | |
| 3 | -$2.17M | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$2.12M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.51M |
